These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 37104009)

  • 21. Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.
    Fan R; Xiao C; Wan X; Cha W; Miao Y; Zhou Y; Qin C; Cui T; Su F; Shan X
    RNA Biol; 2019 Jun; 16(6):707-718. PubMed ID: 30900502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics.
    Tyagi N; Arora S; Deshmukh SK; Singh S; Marimuthu S; Singh AP
    J Biomed Nanotechnol; 2016 Jan; 12(1):28-42. PubMed ID: 27301170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs as anti-cancer therapy.
    Garofalo M; Leva GD; Croce CM
    Curr Pharm Des; 2014; 20(33):5328-35. PubMed ID: 24479801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA as a Potential Therapeutic Molecule in Cancer.
    Szczepanek J; Skorupa M; Tretyn A
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trials and Tribulations of MicroRNA Therapeutics.
    Seyhan AA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.
    Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer.
    Grillone K; Caridà G; Luciano F; Cordua A; Di Martino MT; Tagliaferri P; Tassone P
    J Transl Med; 2024 Aug; 22(1):731. PubMed ID: 39103911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-based Targeted Therapeutics in Pancreatic Cancer.
    Gurbuz N; Ozpolat B
    Anticancer Res; 2019 Feb; 39(2):529-532. PubMed ID: 30711926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
    Otmani K; Rouas R; Lewalle P
    Front Immunol; 2022; 13():913951. PubMed ID: 36189271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development.
    Çetinkaya M; Baran Y
    Curr Pharm Biotechnol; 2023; 24(7):913-925. PubMed ID: 35927824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The duality of oncomiR addiction in the maintenance and treatment of cancer.
    Cheng CJ; Slack FJ
    Cancer J; 2012; 18(3):232-7. PubMed ID: 22647359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in miRNA-Mediated Mucin Regulation.
    Krishn SR; Batra SK; Kaur S
    Curr Pharmacol Rep; 2015 Dec; 1(6):355-364. PubMed ID: 27867838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNA as a Potential Target for Multiple Myeloma Therapy-Current Knowledge and Perspectives.
    Szudy-Szczyrek A; Ahern S; Krawczyk J; Szczyrek M; Hus M
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNAs: Master regulators as potential therapeutics in cancer.
    Garofalo M; Croce CM
    Annu Rev Pharmacol Toxicol; 2011; 51():25-43. PubMed ID: 20809797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNAs as oncogenes and tumor suppressors.
    Zhang B; Pan X; Cobb GP; Anderson TA
    Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-based therapy for glioblastoma: Opportunities and challenges.
    Lei Q; Yang Y; Zhou W; Liu W; Li Y; Qi N; Li Q; Wen Z; Ding L; Huang X; Li Y; Wu J
    Eur J Pharmacol; 2023 Jan; 938():175388. PubMed ID: 36403686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies.
    Brillante S; Volpe M; Indrieri A
    Hum Gene Ther; 2024 Sep; 35(17-18):628-648. PubMed ID: 39150011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecules targeting microRNA for cancer therapy: Promises and obstacles.
    Wen D; Danquah M; Chaudhary AK; Mahato RI
    J Control Release; 2015 Dec; 219():237-247. PubMed ID: 26256260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.